In this paper, a mistake has been found in Figure 2C. The image for 0 hour of miR-NC group was inadvertently presented with the same image for 0 hour of miR-143 treatment. We have accordingly replaced the Figure 2C with the corrected image. The corrected Figure 2 is enclosed. Change in representative image does not affect the interpretation of our data. The figure legend is correct as published and is also shown below for reference. The error has no bearings on the interpretation of the results, nor do they influence the conclusions of the work.
. 2021 Jul 15;13(7):8522–8523.
MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer
Lufei Wang
1, Jin He
2, Hongmei Xu
2, Longjie Xu
2, Na Li
2
Lufei Wang
1Department of Ophthalmology, The Second Hospital of Jilin University, Changchun 130041, Jilin Province, P. R. China
Find articles by Lufei Wang
Jin He
2Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, P. R. China
Find articles by Jin He
Hongmei Xu
2Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, P. R. China
Find articles by Hongmei Xu
Longjie Xu
2Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, P. R. China
Find articles by Longjie Xu
Na Li
2Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, P. R. China
Find articles by Na Li
1Department of Ophthalmology, The Second Hospital of Jilin University, Changchun 130041, Jilin Province, P. R. China
2Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, P. R. China
✉
Address correspondence to: Na Li, Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun 130021, Jilin Province, P. R. China. E-mail: linawcywys@sina.com
Received 2021 May 18; Accepted 2021 Jun 7; Collection date 2021.
AJTR Copyright © 2021
PMCID: PMC8340208 PMID: 34377350
This corrects the article "MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer" in volume 8 on page 2716.